A detailed history of American Capital Advisory, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, American Capital Advisory, LLC holds 550 shares of ABT stock, worth $61,952. This represents 0.04% of its overall portfolio holdings.

Number of Shares
550
Previous 570 3.51%
Holding current value
$61,952
Previous $57.7 Million 4.89%
% of portfolio
0.04%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

SELL
$100.73 - $112.44 $2,014 - $2,248
-20 Reduced 3.51%
550 $60.5 Million
Q1 2024

Apr 29, 2024

BUY
$109.52 - $120.96 $2,190 - $2,419
20 Added 3.64%
570 $57.7 Million
Q4 2023

Apr 09, 2024

BUY
$90.19 - $110.4 $49,604 - $60,720
550 New
550 $60.5 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track American Capital Advisory, LLC Portfolio

Follow American Capital Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Capital Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on American Capital Advisory, LLC with notifications on news.